ROSEMONT, Ill., Sept. 22, 2026 /PRNewswire/ -- The American Academy of Orthopaedic Surgeons (AAOS) announced that Enovis™ has expanded its support of the AAOS Registry Program, becoming the first industry partner to sponsor multiple AAOS registries. A longtime sponsor of the American Joint Replacement Registry (AJRR), Enovis will now also support the Shoulder & Elbow Registry (SER) through 2027.
Enovis becomes first multi-registry industry sponsor of AAOS Registry Program
3 min read Premium comments
AAOSEnovis#ajrrThe American Academy of Orthopaedic SurgeonsAmerican Joint Replacement RegistrySERShoulder & Elbow Registryexpanded support
WHY NOW? BUILDING A MORE COMPLETE PICTURE OF SHOULDER AND ELBOW CARE
Shoulder and elbow conditions can make everyday movement painful and difficult. Each year, nearly 2 million people in the United States visit a physician because of rotator cuff tears alone, underscoring the need for reliable data on treatments and outcomes. The 2026 Annual Report includes implant component-level data for the first time, giving clinicians more detail to evaluate treatment patterns and inform patient care. Support from partners like Enovis helps advance this work and strengthen the registry as a resource for the orthopaedic community.
WHAT THE LEADERS ARE SAYING
"As surgeons, we learn from the patient in front of us, but registry data allow us to see patterns across thousands of procedures," said Carolyn M. Hettrich, MD, MPH, FAAOS, chair of the AAOS Shoulder & Elbow Registry Steering Committee. "Industry partners help provide the resources needed to expand data collection and turn those insights into meaningful improvements in care. Enovis' support will help the SER continue to grow as a resource for understanding shoulder and elbow care and identifying where we can do better."
"At Enovis, we recognize the critical role registries play in advancing patient care and generating the clinical evidence needed to support innovation," said Damien McDonald, CEO of Enovis. "As the first industry partner with the American Shoulder & Elbow Registry, we are excited to work alongside registry leaders and surgeons to strengthen data quality, increase participation, and expand understanding of outcomes in shoulder arthroplasty. This collaboration reinforces our long-term commitment to evidence generation and to developing technologies that improve the lives of patients worldwide."
The SER includes representatives from the American Shoulder and Elbow Surgeons (ASES), the American Orthopaedic Society for Sports Medicine (AOSSM), the Arthroscopy Association of North America (AANA), and the American Society for Surgery of the Hand (ASSH).
AAOS Registry Program
The AAOS Registry Program's mission is to improve orthopaedic care through the collection, analysis, and reporting of actionable data. The American Joint Replacement Registry (AJRR), the Academy's hip and knee replacement registry, is the cornerstone of the AAOS's Registry Program, and the world's largest national registry of hip and knee joint replacement data by annual procedural count, with more than 5 million procedures contained within its database. Additional registries include the Musculoskeletal Tumor Registry (MsTR), the SER, and the American Spine Registry (ASR), a collaborative effort between the American Association of Neurological Surgeons (AANS) and AAOS.
About AAOS
With more than 39,000 members, the American Academy of Orthopaedic Surgeons is the world's largest medical association of musculoskeletal specialists. AAOS is the trusted leader in advancing musculoskeletal health. It provides the highest quality, most comprehensive education to help orthopaedic surgeons and allied health professionals at every career level best treat patients daily. AAOS is the source of information on bone and joint conditions, treatments, and related musculoskeletal healthcare issues; and it leads the healthcare discussion on advancing quality.
About Enovis
Enovis™ (NYSE: ENOV) is a global medical technology innovator dedicated to improving lives by developing clinically differentiated solutions that enhance patient outcomes and restore motion for life. We partner with the brightest minds in health to advance care that is smarter, personalized, and more effective, while improving operational efficiency for surgeons and clinicians around the world. Enovis solutions impact the well-being of millions of patients wherever they are on their pathway to health. Discover more about Enovis at www.enovis.com and follow us on Facebook, Instagram, LinkedIn and X.
SOURCE American Academy of Orthopaedic Surgeons
Author
TH
TJ Halvorson
The De Angelis Group | Orthopedics This Week | MSK Innovations
Why This Matters
Two Perspectives
MBA Lens: Economic and industry impact
Enovis has strategically expanded its support of the AAOS Registry Program, becoming the first industry partner to sponsor multiple registries, including the American Joint Replacement Registry (AJRR) and the Shoulder & Elbow Registry (SER). This move enhances Enovis's market intelligence and influence, leveraging comprehensive data to inform product development and potentially shape future reimbursement landscapes and competitive positioning in the orthopedics sector.
- This expanded sponsorship provides Enovis with deeper insights into treatment patterns and outcomes, potentially influencing product adoption and market share.
- The collaboration reinforces Enovis's commitment to evidence generation, which can support innovation and differentiate its solutions in a competitive market.
PhD Lens: Clinical and outcomes impact
Enovis's expanded sponsorship of the AAOS Shoulder & Elbow Registry (SER) is crucial for advancing clinical evidence and improving patient outcomes in shoulder and elbow care. This support facilitates the collection and analysis of extensive registry data, including new implant component-level details, providing clinicians with valuable insights into treatment patterns and efficacy. Such data are vital for identifying areas to enhance care.
- Registry data, now including implant component-level information, offers detailed insights into treatment variability and outcomes for conditions like rotator cuff tears.
- The collaboration strengthens the SER as a resource for understanding clinical effectiveness and identifying opportunities for improving surgical techniques and patient management.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.